retatrutide triple agonist glp-1 gip glucagon ly3437943 for Weight Loss: What It Is, How It Works & Side Effects Glucagon and retatrutide‐induced ANGPTL3/8 secretion

Studies show that without ongoing medication: Most patients regain 75-90% of lost weight within two years Many report unusually strong hunger signals after discontinuation Metabolic adaptation makes weight maintenance significantly more challenging Of all the potential long-term effects, bone health deserves special attention because: Bone loss occurs silently : Unlike digestive side effects that are immediately noticeable, bone loss happens gradually with no symptoms until a fracture occurs The effects can be permanent : Once significant bone loss occurs, it can be difficult to fully restore The consequences are serious : Osteoporotic fractures can lead to chronic pain, disability, and in the case of hip fractures, a 20-30% mortality rate in the first year Combination risk factors : Many people taking GLP-1 medications already have other risk factors for osteoporosis, creating a perfect storm for bone health problems Also read: Does Ozempic Cause Osteoporosis

If residual schizophrenia reflects neural damage due to oxidative stress, reduced levels of glutamate and glutathione should be most marked in patients with residual schizophrenia

Commentary: Practice Patterns and Potential Impact on Quality Measurements for a Practicing Physician

Diabetes Care 44, 14621471